FRI0584 Rheumatic and musculoskeletal disorders related to immune checkpoint inhibitors in cancer pa...
FRI0584 Rheumatic and musculoskeletal disorders related to immune checkpoint inhibitors in cancer patients: a prospective single-institution study
About this item
Full title
Author / Creator
Marie, K , Rouxel, L , Veillon, R , Martin, F , Dutriaux, C , Pham-Ledard, A , Prey, S , Beylot-Barry, M , Gross-Goupil, M , Bannwarth, B , Richez, C , Mehsen-Cetre, N and Schaeverbeke, T
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
BackgroundImmune checkpoint inhibitors (ICI) targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) axis have been a major advance in cancer immunotherapy. By enhancing T cell activity, unprecedented long-lasting tumour responses are observed in selected cancers but some patients experience immune...
Alternative Titles
Full title
FRI0584 Rheumatic and musculoskeletal disorders related to immune checkpoint inhibitors in cancer patients: a prospective single-institution study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2033911690
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2033911690
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2017-eular.6703
